Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 8, 2012, Pages 818-827

  Yood, Marianne Ulcickas ^a,b,c   Wells, Karen E ^b   Alford, Sharon Hensley ^b   Dakki, Heather ^b   Beiderbeck, Annette B ^d   Hurria, Arti ^e   Gross, Cary P ^f   Oliveria, Susan A ^a  

^a EpiSource   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d Abbott   (France)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cardiotoxic agents; Cardiotoxicity risk; Chemotherapy

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DDP; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; EXEMESTANE; FLUOXYMESTERONE; FULVESTRANT; GEFITINIB; GEMCITABINE; GOSERELIN; IRINOTECAN; LETROZOLE; LEUPRORELIN; MEGESTROL ACETATE; METHOTREXATE; MITOXANTRONE; NAVELBINE; PACLITAXEL; PROGESTERONE RECEPTOR; TEMOZOLOMIDE; THIOTEPA; TOREMIFENE; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGE; AGED; ANGINA PECTORIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH CARE ORGANIZATION; HEALTH STATUS; HEART ARREST; HEART ARRHYTHMIA; HEART BLOCK; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MYOCARDITIS; PRIORITY JOURNAL; RACE; SIDE EFFECT; SYSTEMIC THERAPY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARDIOTOXINS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84864338999     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3239     Document Type: Article

References (27)

1. Breast Cancer Facts and Figures. 2003. (accessed April 15, 2006).
2. National Health Interview Survey. 2002. (accessed April 15, 2006).
3. Fischer D, Durivage H, Knobf M, et al. The Cancer Chemotherapy Handbook. 6 ed. 2003, Lippincott Williams & Wilkins: Philadelphia, PA.
4. Shan K, Lincoff A, Young J. Anthracycline-Induced Cardiotoxicity. Ann Intern Med 1996; 125(1): 47-58.
5. Von Hoff D, Layard M, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91: 710-717.
6. Von Hoff D, Rozencweig M, Piccart M. The cardiotoxicity of anticancer agents. Semin Oncol 1982; 9: 23-33.
7. Allen A. The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 1992; 19: 529-542.
8. Swain S, Whaley F, Ewer M. Congestive heart failure in patients treated with doxorubicin. A retrospective analysis of three trials. Cancer 2003; 97: 2869-2879.
9. Wiseman L, Spencer C. Dexrazoxane: A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Drugs 1998; 56(3): 385-403.
10. Doyle J, Neugut A, Jacobson J, et al. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol 2005; 23: 8597-8605.
11. Pinder M, Duan Z, Goodwin J, et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 2007; 25: 3808-3815.
12. Suter T, Cook-Bruns N, Barton C. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer. Breast 2004; 13: 173-183.
13. Healey Bird B, Swain S. Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems. Clin Cancer Res 2008; 14: 14-24.
14. National Comprehensive Cancer Network. NCCN Task Force Report: Breast Cancer in Older Women, Hollywood, FL; May 2008. (accessed on August 11, 2008).
15. Skeel R. Handbook of Cancer Chemotherapy. 6 ed. 2003. Lippincott Williams & Wilkins: Philadelphia, PA.
16. Ganz P, Hussey M, Moinpour C, et al. Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897. J Clin Oncol 2008; 26: 1223-1230.
17. Jensen B, Skovsgaard T, Nielsen S. Functional Monitoring of anthracycline cardiotoxcity: A prospective, blinded, long-term observational study of outcome in 120 patients. Ann Onco 2002; 13: 699-709.
18. Sukel M, Breekveldt-Postma N, Erkens J, et al. Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice. Pharmacoepidemiol Drug Saf 2008; 17(2): 125-134.
19. Ulcickas Yood M, Oliveria S, Boyer JG, et al. Colon polyp recurrence in a managed care population. Arch Intern Med 2003. 163: 422-426.
20. Ulcickas Yood M, Watkins E, Wells K, et al. The impact of NSAID or COX-2 use on the initiation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006. 15: 852-860.
21. Ries L, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. 2006. (accessed April 15, 2006).
22. Murthy V, Krumholz H, Gross C. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004; 291: 2720-2726.
23. Gross C, Wong N, Dubin J, et al. Enrollment of older persons in cancer trials after the Medicare reimbursement policy change. Arch Intern Med 2005; 156(13): 1514-1520.
24. Masoudi F, Havranek E, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250-257.
25. Silliman R. What constitutes optimal care for older women with breast cancer? J Clin Oncol 2003; 21(19): 3554-3556.
26. Gross C, Steiner C, Bass E, et al. Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy. JAMA 2000; 284: 2886-2893.
27. Gross C, Garg P, Krumholz H. The generalizability of observational data to elderly patients was dependent on the research question in a systematic review. J Clin Epidemiol 2005; 58: 130-137.